These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15046599)

  • 1. Role of class IA phosphoinositide 3-kinase in B lymphocyte development and functions.
    Koyasu S
    Biochem Soc Trans; 2004 Apr; 32(Pt 2):320-5. PubMed ID: 15046599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical role of class IA PI3K for c-Rel expression in B lymphocytes.
    Matsuda S; Mikami Y; Ohtani M; Fujiwara M; Hirata Y; Minowa A; Terauchi Y; Kadowaki T; Koyasu S
    Blood; 2009 Jan; 113(5):1037-44. PubMed ID: 18927440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphoinositide 3-kinase knockout mice: role of p85alpha in B cell development and proliferation.
    Fruman DA; Snapper SB; Yballe CM; Alt FW; Cantley LC
    Biochem Soc Trans; 1999 Aug; 27(4):624-9. PubMed ID: 10917654
    [No Abstract]   [Full Text] [Related]  

  • 4. Cbl-b negatively regulates B cell antigen receptor signaling in mature B cells through ubiquitination of the tyrosine kinase Syk.
    Sohn HW; Gu H; Pierce SK
    J Exp Med; 2003 Jun; 197(11):1511-24. PubMed ID: 12771181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frontline: The p85alpha isoform of phosphoinositide 3-kinase is essential for a subset of B cell receptor-initiated signaling responses.
    Hess KL; Donahue AC; Ng KL; Moore TI; Oak J; Fruman DA
    Eur J Immunol; 2004 Nov; 34(11):2968-76. PubMed ID: 15384044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class IA phosphoinositide 3-kinase modulates basal lymphocyte motility in the lymph node.
    Matheu MP; Deane JA; Parker I; Fruman DA; Cahalan MD
    J Immunol; 2007 Aug; 179(4):2261-9. PubMed ID: 17675487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice.
    Okkenhaug K; Bilancio A; Farjot G; Priddle H; Sancho S; Peskett E; Pearce W; Meek SE; Salpekar A; Waterfield MD; Smith AJ; Vanhaesebroeck B
    Science; 2002 Aug; 297(5583):1031-4. PubMed ID: 12130661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphoinositide 3-kinases in immunity: lessons from knockout mice.
    Sasaki T; Suzuki A; Sasaki J; Penninger JM
    J Biochem; 2002 Apr; 131(4):495-501. PubMed ID: 11926985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A crucial role for the p110delta subunit of phosphatidylinositol 3-kinase in B cell development and activation.
    Clayton E; Bardi G; Bell SE; Chantry D; Downes CP; Gray A; Humphries LA; Rawlings D; Reynolds H; Vigorito E; Turner M
    J Exp Med; 2002 Sep; 196(6):753-63. PubMed ID: 12235209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PI3K in lymphocyte development, differentiation and activation.
    Okkenhaug K; Vanhaesebroeck B
    Nat Rev Immunol; 2003 Apr; 3(4):317-30. PubMed ID: 12669022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of PI3K in immune cells.
    Koyasu S
    Nat Immunol; 2003 Apr; 4(4):313-9. PubMed ID: 12660731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary roles for CD19 and Bruton's tyrosine kinase in B lymphocyte signal transduction.
    Fujimoto M; Poe JC; Satterthwaite AB; Wahl MI; Witte ON; Tedder TF
    J Immunol; 2002 Jun; 168(11):5465-76. PubMed ID: 12023340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha.
    Fruman DA; Snapper SB; Yballe CM; Davidson L; Yu JY; Alt FW; Cantley LC
    Science; 1999 Jan; 283(5400):393-7. PubMed ID: 9888855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement for phosphoinositide 3-kinase p110delta signaling in B cell antigen receptor-mediated antigen presentation.
    Al-Alwan MM; Okkenhaug K; Vanhaesebroeck B; Hayflick JS; Marshall AJ
    J Immunol; 2007 Feb; 178(4):2328-35. PubMed ID: 17277138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation.
    Fujimoto M; Poe JC; Jansen PJ; Sato S; Tedder TF
    J Immunol; 1999 Jun; 162(12):7088-94. PubMed ID: 10358152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PI3K and Btk differentially regulate B cell antigen receptor-mediated signal transduction.
    Suzuki H; Matsuda S; Terauchi Y; Fujiwara M; Ohteki T; Asano T; Behrens TW; Kouro T; Takatsu K; Kadowaki T; Koyasu S
    Nat Immunol; 2003 Mar; 4(3):280-6. PubMed ID: 12563258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PI3K-signalling in B- and T-cells: insights from gene-targeted mice.
    Okkenhaug K; Vanhaesebroeck B
    Biochem Soc Trans; 2003 Feb; 31(Pt 1):270-4. PubMed ID: 12546700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Mechanisms of Human Disease Mediated by Oncogenic and Primary Immunodeficiency Mutations in Class IA Phosphoinositide 3-Kinases.
    Dornan GL; Burke JE
    Front Immunol; 2018; 9():575. PubMed ID: 29616047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and function of phosphoinositide 3-kinases.
    Wymann MP; Pirola L
    Biochim Biophys Acta; 1998 Dec; 1436(1-2):127-50. PubMed ID: 9838078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of phosphoinositide 3-kinase regulatory isoforms in development and actin rearrangement.
    Brachmann SM; Yballe CM; Innocenti M; Deane JA; Fruman DA; Thomas SM; Cantley LC
    Mol Cell Biol; 2005 Apr; 25(7):2593-606. PubMed ID: 15767666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.